Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Download bibliography of all 933 studies, highest score first: BibTeX (.bib) · RIS (.ris)
Highest usefulness score first. Studies without a score come last.
-
In a cell free assay, ADAM10 activity was found to be significantly lower in apoE4 samples compared to apoE2. 7WCHO cells over expressing wild type AβPP exposed to apoE4 demonstrated reduced formation of sAβPPα compared to other apoE isoforms.
-
38/100
Alzheimer's disease (AD) displays a long asymptomatic stage before dementia.
-
Alzheimer's disease (AD) has a very strong genetic component, whose characterization has become an essential part of efforts to understand the pathophysiological processes of the disease.
-
In this study, we developed a network-based deep-learning approach, termed deepDR, for in silico drug repurposing by integrating 10 networks: one drug-disease, one drug-side-effect, one drug-target and seven drug-drug networks.
-
Prediction of disease risk is an essential part of preventative medicine, often guiding clinical management.
-
Multiplex immunoassay conducted on brain lysates showed that alcohol drinking upregulated primary markers of AD pathology in 3xTg-AD mice: Aβ 42/40 ratio in the lateral entorhinal and prefrontal cortex and total Tau expression in the lateral entorhinal cortex, medial prefrontal cortex, and amygdala at 1-month post alcohol exposure.
-
Alzheimer's disease (AD) is considered a polygenic disorder.
-
Apolipoprotein E (apoE), a 34 kDa circulating glycoprotein of 299 amino acids, predominantly synthesised in the liver, associates with triglyceride-rich lipoproteins to mediate the clearance of their remnants after enzymatic lipolysis in the circulation.
-
Alzheimer disease (AD) is characterized by wide heterogeneity in cognitive and behavioural syndromes, risk factors and pathophysiological mechanisms.
-
Investigators have long suspected that pathogenic microbes might contribute to the onset and progression of Alzheimer's disease (AD) although definitive evidence has not been presented.
-
Mechanisms of epigenetic regulation, including DNA methylation, chromatin remodeling, and histone post-translational modifications, are involved in multiple aspects of neuronal function and development.
-
The apolipoprotein E4 (APOE4) variant is the single greatest genetic risk factor for sporadic Alzheimer's disease (sAD).
-
Circular RNAs (circRNAs) represent a special group of noncoding single-stranded highly stable ribonucleic acid entities abundant in the eukaryotic transcriptome.
-
Alzheimer's disease (AD) is a genetically heterogeneous neurodegenerative disorder caused by fully penetrant single gene mutations in a minority of cases, while the majority of cases are sporadic or show modest familial clustering.
-
Human apolipoprotein E (ApoE) apolipoprotein is primarily expressed in three isoforms (ApoE2, ApoE3, and ApoE4) that differ only by two residues.
-
Alzheimer's disease (AD) (MIM: 104300) is a highly heritable disease with great complexity in its genetic contributors, and represents the most common form of dementia.
-
Alzheimer's disease (AD), the most common form of senile dementia, is a genetically complex disorder.
-
Genetic and environmental protective factors and risks modulate brain structure and function in neurodegenerative diseases and their preclinical stages.
-
The APOE gene is one of currently only two genes that have consistently been associated with longevity.
-
Apolipoprotein (apo) E was initially described as a lipid transport protein and major ligand for low density lipoprotein (LDL) receptors with a role in cholesterol metabolism and cardiovascular disease.
-
The genetics dataset yielded two subtypes of AD characterized mainly by the presence/absence of the apolipoprotein E (APOE) ε4 genotype, but also involving differential presence of risk alleles of CD2AP, SPON1 and LOC39095 SNPs that were associated with differences in the respective patterns of brain atrophy, especially in the precuneus.
-
Genome-wide association studies have associated clusterin (CLU) variants with Alzheimer's disease (AD).
-
Our data indicated that 18p11.32 (rs1992269, P = 9.77 × 10(-7)), CNTNAP2 (rs802571, P = 1.26 × 10(-6)), and 12q24.23 (rs11613092, P = 6.85 × 10(-6)) were suggestive loci for susceptibility to LOAD.
-
Two of three examined members of this family presented with the usual amnestic pattern.
-
Alarming epidemiological features of Alzheimer's disease impose curative treatment rather than symptomatic relief.
From across this topic
10 of the 933 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease
- Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
- Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration
- Transcription Factor-Wide Association Studies to Identify Functional SNPs in Alzheimer's Disease
- Polygenicity and APOE ε4 shape response to intervention in mild cognitive impairment
- The genetic defect causing familial Alzheimer's disease maps on chromosome 21
- Genetic variants for Alzheimer's disease and comorbid conditions
- Polygenic effects on the risk of Alzheimer's disease in the Japanese population
- Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
- A drug repositioning algorithm based on a deep autoencoder and adaptive fusion